Literature DB >> 25400480

Intraductal papillary neoplasm of the bile duct developing in a patient with primary sclerosing cholangitis: a case report.

Hiroyuki Hachiya1, Junji Kita1, Takayuki Shiraki1, Yukihiro Iso1, Mitsugi Shimoda1, Keiichi Kubota1.   

Abstract

We report a case of intraductal papillary neoplasm of the bile duct (IPNB) that developed in a patient with primary sclerosing cholangitis. A 46-year-old woman was admitted to our hospital with obstructive jaundice. The liver function tests demonstrated increased serum liver enzyme levels. Computed tomography showed dilatation of the intrahepatic bile ducts. Abdominal ultrasonography revealed a highly echoic protruding lesion in the posterior bile duct near the right lobe of the liver. The lesion was suspected to be IPNB, but we were unable to confirm whether it was a carcinoma. A right hepatectomy was performed, and this showed that the dilated bile duct was filled with mucin and contained several yellowish papillary tumors. Histologically, the neoplastic biliary epithelium showed papillary growth in the dilated lumen. The tumor was diagnosed as IPNB, high-grade intraepithelial neoplasia secreting abundant mucin. No recurrence has been detected 3 years after surgery.

Entities:  

Keywords:  Cholangiocarcinoma; High-grade intraepithelial neoplasia; Intraductal papillary neoplasm of the bile duct; Premalignant lesion; Primary sclerosing cholangitis

Mesh:

Substances:

Year:  2014        PMID: 25400480      PMCID: PMC4229561          DOI: 10.3748/wjg.v20.i42.15925

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis.

Authors:  Moueen Bu-Ghanim; Arief Suriawinata; Mary Killackey; Myron E Schwartz; David Jaffe; M Isabel Fiel
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

2.  Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.

Authors:  Yoh Zen; Motoko Sasaki; Takahiko Fujii; Tse-Ching Chen; Miin-Fu Chen; Ta-Sen Yeh; Yi-Yin Jan; Shiu-Feng Huang; Yuji Nimura; Yasuni Nakanuma
Journal:  J Hepatol       Date:  2005-12-05       Impact factor: 25.083

3.  Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study.

Authors:  Johan Fevery; Liesbet Henckaerts; Robin Van Oirbeek; Séverine Vermeire; Paul Rutgeerts; Frederik Nevens; Werner Van Steenbergen
Journal:  Liver Int       Date:  2011-07-05       Impact factor: 5.828

4.  Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association.

Authors:  Keiichi Kubota; Yasuni Nakanuma; Fukuo Kondo; Hiroyuki Hachiya; Masaru Miyazaki; Masato Nagino; Masakazu Yamamoto; Hiroyuki Isayama; Masami Tabata; Hisafumi Kinoshita; Terumi Kamisawa; Kazuo Inui
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-08-01       Impact factor: 7.027

5.  Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.

Authors:  Geunyoung Jung; Kwang-Min Park; Seung Soo Lee; Eunsil Yu; Seung-Mo Hong; Jihun Kim
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

6.  Mucin-producing bile duct carcinoma arising from primary sclerosing cholangitis: a case report.

Authors:  Shigeki Yokomuro; Yasuo Arima; Yoshiaki Mizuguchi; Tetsuya Shimizu; Yutaka Kawahigashi; Tomohiro Kannda; Masao Arai; Eiji Uchida; Koho Akimaru; Takashi Tajiri
Journal:  J Nippon Med Sch       Date:  2007-02       Impact factor: 0.920

7.  Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.

Authors:  Yoh Zen; Alberto Quaglia; Nigel Heaton; Mohamed Rela; Bernard Portmann
Journal:  Histopathology       Date:  2011-12       Impact factor: 5.087

8.  Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  Kelly Burak; Paul Angulo; Tousif M Pasha; Kathleen Egan; Jan Petz; Keith D Lindor
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

9.  Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.

Authors:  Jason T Lewis; Jayant A Talwalkar; Charles B Rosen; Thomas C Smyrk; Susan C Abraham
Journal:  Am J Surg Pathol       Date:  2010-01       Impact factor: 6.394

Review 10.  Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.

Authors:  Yasuni Nakanuma; Yoh Zen; Kenichi Harada; Hiroko Ikeda; Yasunori Sato; Takeshi Uehara; Motoko Sasaki
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-08-14       Impact factor: 7.027

  10 in total
  2 in total

1.  Surgical Treatment of Intraductal Papillary Neoplasm of the Bile Duct: A Report of Two Cases and Review of the Literature.

Authors:  Binjie Li; Zhiqiang Liu; Zhuo Meng; Mingyang Li; Weijun Tian; Quanyan Liu
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 2.  Benign biliary neoplasms and biliary tumor precursors.

Authors:  Samantha Sarcognato; Diana Sacchi; Matteo Fassan; Luca Fabris; Massimiliano Cadamuro; Giacomo Zanus; Ivana Cataldo; Claudia Covelli; Paola Capelli; Alberto Furlanetto; Maria Guido
Journal:  Pathologica       Date:  2021-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.